Matthew P. Wallen

Matthew P. Wallen

Auto-generated profile, based on publicly available information

Matthew P. Wallen

Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, SA, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MWMatthew P Wallen
Matthew P Wallen
SGSjaan Gomersall
Sjaan Gomersall
SKShelley Keating
Shelley Keating
UWUlrik Wisløff
Ulrik Wisløff
JCJeff S Coombes
Jeff S Coombes
Wrist-worn monitors claim to provide accurate measures of heart rate and energy expenditure. People wishing to lose weight use these devices to monitor energy balance, however the accuracy of these devices to measure such parameters has not been established. To determine the accuracy of four wrist-worn devices (Apple Watch, Fitbit Charge HR, Samsung Gear S and Mio Alpha) to measure heart rate and energy expenditure at rest and during exercise. Twenty-two healthy volunteers (50% female; aged 24 ± 5.6 years) completed ~1-hr protocols involving supine and seated rest, walking and running on a treadmill and cycling on an ergometer. Data from the devices collected during the protocol were compared with reference methods: electrocardiography (heart rate) and indirect calorimetry (energy expenditure). None of the devices performed significantly better overall, however heart rate was consistently more accurate than energy expenditure across all four devices. Correlations between the devices and reference methods were moderate to strong for heart rate (0.67–0.95 [0.35 to 0.98]) and weak to strong for energy expenditure (0.16–0.86 [-0.25 to 0.95]). All devices underestimated both outcomes compared to reference methods. The percentage error for heart rate was small across the devices (range: 1–9%) but greater for energy expenditure (9–43%). Similarly, limits of agreement were considerably narrower for heart rate (ranging from -27.3 to 13.1 bpm) than energy expenditure (ranging from -266.7 to 65.7 kcals) across devices. These devices accurately measure heart rate. However, estimates of energy expenditure are poor and would have implications for people using these devices for weight loss.

1 September 2017 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
JRJoyce S. Ramos
Joyce S. Ramos
LDLance C. Dalleck
Lance C. Dalleck
FBFabio Borrani
Fabio Borrani
KBKassia S. Beetham
Kassia S. Beetham
MWMatthew P. Wallen
Matthew P. Wallen
JCJeff S. Coombes
Jeff S. Coombes
Background: High-intensity interval training (HIIT) is superior to moderate-intensity continuous training (MICT) at improving cardiometabolic risk. However, the optimal volume of HIIT to reduce the severity of the metabolic syndrome (MetS) has yet to be investigated. The aim of this study was to examine the impact of different volumes of HIIT and MICT on MetS severity (MetS z-score). Methods: This was a substudy of the “Exercise in prevention of Metabolic Syndrome” (EX-MET) multicenter trial, reporting data collected at the Brisbane site. Ninety-nine adults diagnosed with MetS were randomized to one of the following 16-week interventions: (1) MICT [n = 34, 30 min at 60%–70% heart rate (HR) peak/session, 150 min/week]; (2) 4HIIT (n = 34, 4 × 4 min bouts at 85%–95% HR peak, interspersed with 3 min active recovery at 50%–70% HR peak, 114 min/week); or (3) 1HIIT (n = 31, 1 × 4 min bout at 85%–95% HR peak, 51 min/week). Z-scores were derived from levels of MetS risk factors before and after the intervention. Results: Eighty-one participants completed post-testing (MICT, n = 26; 4HIIT, n = 28, 1HIIT, n = 27). After excluding 16 participants who had a change in medication dosage or type during the intervention, a total of 65 participants were included in the analysis [MICT, n = 22, age 55 ± 10 years, body mass index (BMI) 32 ± 6 kg/m; 4HIIT, n = 22, 56 ± 10 years, 35 ± 9 kg/m2; 1HIIT, n = 21, 57 ± 8 years, 32 ± 5 kg/m). MetS severity reduced following all interventions (pre- to post-MetS z-score: MICT, 1.80 ± 1.93 to 0.90 ± 1.93; 4HIIT, 2.75 ± 2.56 to 2.17 ± 2.71; 1HIIT, 2.48 ± 3.38 to 0.84 ± 2.98), with no significant differences between groups. There were no reported adverse events that were directly related to the exercise interventions. Conclusions: Low-volume HIIT (51 min/week) was as effective as high-volume HIIT (114 min/week) and MICT (150 min/week) in ameliorating MetS severity.

1 February 2024 in eClinicalMedicine
Verified
Journal Article
Open access
HWHenry C.Y. Wong
Henry C.Y. Wong
MWMatthew P. Wallen
Matthew P. Wallen
ACAdrian Wai Chan
Adrian Wai Chan
NDNarayanee Dick
Narayanee Dick
PBPierluigi Bonomo
Pierluigi Bonomo
KYKatsuhide Yoshidome
Katsuhide Yoshidome
Developing strategies to prevent breast cancer-related arm lymphoedema (BCRAL) is a critical unmet need because there are no effective interventions to eradicate it once it reaches a chronic state. Certain strategies such as prospective surveillance programs and prophylactic lymphatic reconstruction have been reported to be effective in clinical trials. However, a large variation exists in practice based on clinician preference, organizational standards, and local resources. A two-round international Delphi consensus process was performed from February 27, 2023 to May 25, 2023 to compile opinions of 55 experts involved in the care and research of breast cancer and lymphoedema on such interventions. Axillary lymph node dissection, use of post-operative radiotherapy, relative within-arm volume increase one month after surgery, greater number of lymph nodes dissected, and high body mass index were recommended as the most important risk factors to guide selection of patients for interventions to prevent BCRAL. The panel recommended that prospective surveillance programs should be implemented to screen for and reduce risks of BCRAL where feasible and resources allow. Prophylactic compression sleeves, axillary reverse mapping and prophylactic lymphatic reconstruction should be offered for patients who are at risk for developing BCRAL as options where expertise is available and resources allow. Recommendations on axillary management in clinical T1–2, node negative breast cancer patients with 1–2 positive sentinel lymph nodes were also provided by the expert panel. Routine axillary lymph node dissection should not be offered in these patients who receive breast conservation therapy. Axillary radiation instead of axillary lymph node dissection should be considered in the same group of patients undergoing mastectomy. An individualised approach based on patients' preferences, risk factors for BCRAL, availability of treatment options and expertise of the healthcare team is paramount to ensure patients at risk receive preventive interventions for BCRAL, regardless of where they are receiving care. This study was not supported by any funding. 10.13039/501100009753 RJC received investigator grant support from the 10.13039/501100000925 Australian National Health and Medical Research Council (APP1194051).

29 May 2020 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
MWMatthew P. Wallen
Matthew P. Wallen
DHDeclan Hennessy
Declan Hennessy
SBStephen Brown
Stephen Brown
LELuke Evans
Luke Evans
JRJonathan C Rawstorn
Jonathan C Rawstorn
AHAdrian Hall
Adrian Hall

1 October 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
JRJoyce S. Ramos
Joyce S. Ramos
LDLance C. Dalleck
Lance C. Dalleck
FBFabio Borrani
Fabio Borrani
KBKassia S. Beetham
Kassia S. Beetham
GMGregore Mielke
Gregore Mielke
JCJeff S. Coombes
Jeff S. Coombes

29 July 2019 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
MWMatthew P. Wallen
Matthew P. Wallen
SKShelley Keating
Shelley Keating
AHAdrian Hall
Adrian Hall
IHIngrid J. Hickman
Ingrid J. Hickman
TPToby G. Pavey
Toby G. Pavey
JCJeff S. Coombes
Jeff S. Coombes